The Brief International Cognitive Assessment in Multiple Sclerosis ( BICAMS ): Regression‐based norms for German‐speaking countries
European Journal of Neurology · 2025
DOI: 10.1111/ene.16495 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Neurology, 2025. Verfasst von I K Penner und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Multiple Sclerosis, Neuropsychological Tests, Cognitive Dysfunction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Novartis Pharma GmbH, Novartis Pharma.
Abstract (Originalsprache)
Background and purpose Cognitive impairment in multiple sclerosis (MS) is common and is associated with problems in employment, driving ability, and quality of life. Since cognitive impairment at time of diagnosis is predictive of disability progression, early assessment and annual monitoring is recommended. The Brief International Cognitive Assessment in Multiple Sclerosis (BICAMS) was introduced as a time‐efficient screening tool that can easily be applied in standard clinical care. However, besides application, tests need to be analysed and the raw values obtained must be interpreted accordingly. Since normative values have not been available for German‐speaking countries, BICAMS has not been implemented in clinical routine. The aim of this study was to calculate German normative BICAMS data to improve the current diagnostic process for people with MS.
Methods
Healthy control subjects in different age categories were recruited to enable regression‐based norm analysis. Raw scores for each BICAMS test were converted into scaled scores before they were regressed for age, age squared, gender, and education. The obtained scores were then normalised to a z ‐score by dividing the difference between the scaled score and the predicted score by the root mean squared error of the model.
Results
In all, 237 HCs were recruited (68.8% female, 31.2% male) and examined with BICAMS. Datasets entered the regression‐based norms analysis and formed the basis for a final z ‐score calculation. To simplify handling in everyday clinical practice, nomograms and look‐up tables were created which provide clinicians with age‐ and education‐corrected norms.
Conclusion
Our work fills the gaps between BICAMS application, evaluation and interpretation and will make a significant contribution to more regular cognitive assessment of MS patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
- Cogito Center for Applied Neurocognition and Neuropsychological Research, Düsseldorf, Germany.
- AIMS Lab, Center for Neurosciences, Vrije Universiteit Brussel, Elsene, Brussels, Belgium.
- Department of Experimental Psychology, Heinrich Heine University, Düsseldorf, Germany.
- St Edmund Hall, University of Oxford, Oxford, UK.
ORCID-Profile: I K Penner
Förderung
- Novartis Pharma GmbH
- Novartis Pharma
Zitieren
APA
Penner, I. K., Baijot, J., Filser, M., Bätge, S., Raithel, L., Toth, E., Renner, A., & Nagels, G. (2025). The Brief International Cognitive Assessment in Multiple Sclerosis ( BICAMS ): Regression‐based norms for German‐speaking countries. European Journal of Neurology. https://doi.org/10.1111/ene.16495
Vancouver
Penner IK, Baijot J, Filser M, Bätge S, Raithel L, Toth E, et al. The Brief International Cognitive Assessment in Multiple Sclerosis ( BICAMS ): Regression‐based norms for German‐speaking countries. European Journal of Neurology. 2025. doi:10.1111/ene.16495
BibTeX
@article{Penner2025,
author = {Penner, I K and Baijot, J and Filser, M and Bätge, S and Raithel, L and Toth, E and Renner, A and Nagels, G},
title = {The Brief International Cognitive Assessment in Multiple Sclerosis ( BICAMS ): Regression‐based norms for German‐speaking countries},
journal = {European Journal of Neurology},
year = {2025},
doi = {10.1111/ene.16495}
}
EUVIMED